Biological behaviour and role of endothelial progenitor cells in vascular diseases

Chinese Medical Journal

Volumn 120, Issue 24, 2007, Pages 2297-2303

  Zhang, Qiu Hua ^a   She, Ming Peng ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Atherosclerosis; Cell therapy; Endothelial progenitor cell; Vascular diseases

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CYTOKINE; VASCULOTROPIN RECEPTOR 2;

ADVENTITIA; ANGIOGENESIS; ANTIGEN EXPRESSION; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL DAMAGE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CYTOLOGY; DISEASE COURSE; ENDOTHELIUM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; INTRAVENOUS ADMINISTRATION; ISCHEMIA; MEDICAL LITERATURE; MEDLINE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROCIRCULATION; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPARATION TECHNIQUE; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TISSUE BLOOD FLOW; TISSUE REGENERATION; VASCULAR ENDOTHELIUM;

EID: 38349122160     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200712020-00027     Document Type: Review

References (68)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Roberts N, Jahangiri M, Xu Q. Progenitor cells in vascular disease. J Cell Mol Med 2005; 9: 583-591.
3. Rumpold H, Wolf D, Koeck R, Gunsilius E. Endothelial progenitor cells: a source for therapeutic vasculogenesis? J Cell Mol Med 2004; 8: 509.
4. Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells, limitations for therapy. Arterioscler Thromb Biol 2006; 26: 257-266.
5. Kitta Y, Nakamura T, Kodama Y, Takano H, Umetani K, Fujioka D, et al. Endothelial vasomotor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. J Am Coll Cardiol 2005; 46: 648-655.
6. Hashimoto K, Kataoka N, Nakamura E, Tsujioka K, Kajiya F. Oxidized LDL specifically promotes the initiation of monocyte invasion during transendothelial migration with upregulated PECAM-1 and downregulated VE-cadherin on endothelial junctions. Atherosclerosis 2007; 194: e9-e17.
7. Munzel T, Hink U, Heitzer T, Meinertz T. Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann NY Acad Sci 1999; 874: 386-400.
8. Schwartz SM, Benditt EP. Cell replication in the aortic endothelium: a new method for study of the problem. Lab Invest 1972; 28: 699-707.
9. Davies PF, Remuzzi A, Gordon EJ, Dewey CF Jr. Gimbrone MA Jr. Turbulent fluid shear stress induces vascular endothelial cell turn over in vitro. Proc Natl Acad Sci U S A 1986; 83: 2114-2117.
10. Dernbach E, Urbich C, Brandes RP, Hofmann WK, Zeiher AM, Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004; 104: 3591-3597.
11. Sabin FR. Preliminary note on the differentiation of angioblasts and the method by which they produce blood vessels, blood-plasma and red blood cells as seen in the living chick. J Hematother Stem Cell Res 2002; 11: 5-7.
12. Kinder SJ, Tsang TE, Wakamiya M, Sasaki H, Behringer RR. The organizer of the mouse gastrula is composed of a dynamic population of progenitor cells for the axial mesoderm. Development 2001; 128: 3623-3634.
13. Schreiber M, Wang ZQ, Jochum W, Fetka I, Elliott C, Wagner EF. Placental vascularisation requires the AP-1 component fra1. Development 2000; 127: 4937-4948.
14. Kuhnert F, Campagnolo L, Xiong JW, Lemons D, Fitch MJ, Zou Z, et al. Dosage-dependent requirement for mouse Vezf1 in vascular system development. Dev Biol 2005; 283: 140-156.
15. Oettgen P. Transcriptional regulation of vascular development. Circ Res 2001; 89: 380-388.
16. + cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
17. Vogeli KM, Jin SW, Martin GR, Stainier DY. A common progenitor for haemawpoietic and endothelial lineages in the zebrafish gastrula kevin m. Nature 2006; 443: 337-339.
18. - mononuclear cell population. Circulation 2003; 108: e150.
19. Rehman J, Li J, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169.
20. low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005; 97: 314-322.
21. Loomans CJ, Wan H, de Crom R, van Haperen R, de Boer HC, Leenen PJ, et al. Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression. Arterioscler Thromb Vasc Biol 2006; 26: 1760-1767.
22. Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, et al. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood 2006; 107: 2162-2169.
23. + endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 2006; 98: e20-e25.
24. Shaffer RG, Greene S, Arshi A, Supple G, Bantly A, Moore JS, et al. Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom 2006; 70: 56-62.
25. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano Y, Mori Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischaemic limbs. Circulation 2002; 106: 2019-2025.
26. Griese DP, Ehsan A, Melo LG, Kong D, Zhang L, Mann MJ, et al. Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts. Circulation 2003; 108: 2710-2715.
27. Pesce M, Orlandi A, Iachininoto MG, Straino S, Torella AR, Rizzuti V, et al. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischaemic limb tissues. Circ Res 2003; 93:e51-e62.
28. Sainz J, Al Haj Zen A, Caligiuri G, Demerens C, Urbain D, Lemitre M, et al. Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 2006; 26: 281-286.
29. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95: 911-921.
30. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337-346.
31. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004; 14: 288-293.
32. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, et al. Characterization of mesenchymal stem eells isolated from murine bone marrow by negative selection. J Cell Biochem 2003; 89:1235-1249.
33. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci 2001; 938: 221-229.
34. Iba O, Matsubara H, Nozawa Y, Fujiyama S, Amano K, Mori Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischaemic limbs. Circulation 2002; 106: 2019-2025.
35. Numaguchi Y, Sone T, Okumura K, Ishii M, Morita Y, Kubota R, et al. The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction. Circulation 2006; 114(1 Suppl): 1114-1119.
36. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
37. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 2004; 113: 1258-1265.
38. Grimm PC, Nicherson P, Jefferey J, Savani RC, Gough J, McKeenna RM, et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 2001; 345: 93-97.
39. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15.
40. Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R, et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation 2003; 108: 143-149.
41. Lagaaij EL, Cramer-Knijnenburg GF, van Kemenade FJ, van Es LA, Bruijn JA, van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet 2001; 357: 33-37.
42. Xia JH, Xie AN, Zhang KL, Xu L, Zheng XY. The vascular endothelial growth factor expression and vascular regeneration in infarcted myocardium by skeletal muscle satellite cells. Chin Med J 2006; 119: 117-121.
43. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-668.
44. Murasawa S, Kawamoto A, Horii M, Nakamori S, Asahara T. Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler Thromb Vasc Biol 2005; 25: 1388-1394.
45. Afek A, Abashidze A, Shmilovich H, Deutsch V, Kopolovich J, Miller H, et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein e knockout mice. Arterioscler Thromb Vasc Biol 2005; 25: 2636-2641.
46. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Cire Res 2003; 93: e17-e24.
47. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625-637.
48. Moore KA, Lemischka IR. Stem cells and their niches. Science 2006; 311: 1880-1885.
49. Condorelli G, Borello U, De Angelis L, Latronico M, Sirabella D, Coletta M, et al. Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A 2001; 98: 10733-10738.
50. Murasawa S, Kawamoto A, Horii M, Nakamori S, Asahara T. Niche-dependent translineage commitment of endothelial progenitor cells, not cell fusion in general, into myocardial lineage cells. Arterioscler Thromb Vasc Biol 2005; 25: 1388-1394.
51. Imanishi T, Moriwaki C, Hano T, Nishio I. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005; 23: 1831-1837.
52. Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A. Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006; 187: 423-432.
53. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006; 26: 2140-2146.
54. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004; 109: 220-226.
55. Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, Qin G, et al. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 2006; 114: 2261-2270.
56. Spyridopoulos I, Haendeler J, Urbich C, Brummendorf TH, Oh H, Schneider MD, et al. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004; 110: 3136-3142.
57. Bruno S, Bussolati B, Scacciatella P, Marra S, Sanavio F, Tarella C, et al. Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine 2006; 34: 56-65.
58. Zhu JH, Tao QM, Chen JZ, Wang XX, Zhu JH, Shang YP. Statins contribute to enhancement of the number and the function of endothelial progenitor cells from peripheral blood. Acta Phys Sin 2004; 56: 357-364.
59. Assmus B, Urbich C, Aicher A, Hofmann WK, Haendeler J, Rossig L, et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 2003; 92: 1049-1055.
60. Thum T, Fraccarollo D, Galuppo P, Tsikas D, Frantz S, Ertl G, et al. Bone marrow molecular alterations after myocardial infarction: impact on endothelial progenitor cells. Cardiovasc Res 2006; 70:50-60.
61. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-3427.
62. Sata M, Saiura, A, Kunisato A, Tojo A, Okada S, Tokuhisa T, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409.
63. Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS, Mueske CS, et al. Autologous culture-modifies mononuclear cells confer vascular protection after arterial injury. Circulation 2003; 108: 1520-1526.
64. Iwakura A, Shastry S, Luedemann C, Hamada H, Kawamoto A, Kishore R, et al. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischaemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation 2006; 113: 1605-1614.
65. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS. Transplantation of circulating endothelial progenitor cells restores endothelial function of duded rabbit carotid arteries. Stroke 2004; 35: 2378-2384.
66. Zhang J, Qi H, Wang H, Hu P, Ou L, Guo S, et al. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft. Artif Organs 2006; 30: 898-905.
67. Kong D, Melo LG, Gnecchi M, Zhang L, Mostoslavsky G, Liew CC, et al. Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries. Circulation 2004; 110: 2039-2046.
68. Chen S, Fang W, Qian J, Ye F, Liu Y, Shan S, et al. Improvement of cardiac function after transplantation of autologous bone marrow mwsenchymal stem cells in patients with acute myocardial infarction. Chin Med J 2004; 117: 1443-1448.